12 Sources of evidence considered by the Committee

12 Sources of evidence considered by the Committee

The diagnostics assessment report was prepared by Kleijnen Systematic Reviews Ltd in collaboration with Erasmus University Rotterdam and Maastricht University.

  • Westwood ME, Ramaekers BLT, Whiting P, et al. Procalcitonin (PCT) testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: A systematic review and cost‑effectiveness analysis. January 2015.

Registered stakeholders

The following organisations accepted the invitation to participate in this assessment as registered stakeholders. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Manufacturers/sponsors:

  • bioMerieux UK Ltd

  • Roche Diagnostics Ltd

  • Siemens Healthcare Diagnostics

  • Thermo Fisher Scientific

Professional/specialist and patient/carer groups:

  • British Infection Association

  • Children's Cancer and Leukaemia Group

  • Dudley Group NHS Foundation Trust

  • Group B Strep Support

  • Intensive Care Society

  • Meningitis Research Foundation

  • MRSA Action UK

  • Royal College of Nursing

  • Royal College of Pathologists

  • Royal College of Physicians

  • UK Sepsis Trust

Others

  • British In Vitro Diagnostics Association (BIVDA)

  • Department of Health

  • Department of Microbiology, North West London Hospitals NHS Trust and Ealing Hospital NHS Trust

  • Healthcare Improvement Scotland

  • Imperial College NHS Trust

  • Imutest Limited

  • Integrated Medicines Ltd

  • Manchester Centre for Health Economics, The University of Manchester

  • NHS England

  • Spectral Platforms

  • Welsh Government

  • National Institute for Health and Care Excellence (NICE)